期刊
CANCER DISCOVERY
卷 4, 期 11, 页码 1326-1341出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-13-1037
关键词
-
类别
资金
- Stand Up To Cancer Innovative Research Grant [SU2C-AACR-IRG0509]
- Cookies for Kids' Cancer
- Golf Fights Cancer
- Brian MacIsaac Sarcoma Foundation
- Hyundai Hope on Wheels
- Bear Necessities Pediatric Cancer Foundation
- St. Baldrick's Foundation
- Asociacion Pablo Ugarte
- Xarxa de Bancs de tumors de Catalunya
- Instituto de Salud Carlos III Ministerio de Sanidad y Politica Social Direccion de Terapias Avanzadas y Trasplantes Orden [SAS/2481/2009 TRA-130]
Pediatric Ewing sarcoma is characterized by the expression of chimeric fusions of EWS and ETS family transcription factors, representing a paradigm for studying cancers driven by transcription factor rearrangements. In this study, we describe the somatic landscape of pediatric Ewing sarcoma. These tumors are among the most genetically normal cancers characterized to date, with only EWS-ETS rearrangements identified in the majority of tumors. STAG2 loss, however, is present in more than 15% of Ewing sarcoma tumors; occurs by point mutation, rearrangement, and likely nongenetic mechanisms; and is associated with disease dissemination. Perhaps the most striking finding is the paucity of mutations in immediately targetable signal transduction pathways, highlighting the need for new therapeutic approaches to target EWS-ETS fusions in this disease. SIGNIFICANCE: We performed next-generation sequencing of Ewing sarcoma, a pediatric cancer involving bone, characterized by expression of EWS-ETS fusions. We found remarkably few mutations. However, we discovered that loss of STAG2 expression occurs in 15% of tumors and is associated with metastatic disease, suggesting a potential genetic vulnerability in Ewing sarcoma. (C) 2014 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据